278 related articles for article (PubMed ID: 18974921)
21. Oxidized DJ-1 inhibits p53 by sequestering p53 from promoters in a DNA-binding affinity-dependent manner.
Kato I; Maita H; Takahashi-Niki K; Saito Y; Noguchi N; Iguchi-Ariga SM; Ariga H
Mol Cell Biol; 2013 Jan; 33(2):340-59. PubMed ID: 23149933
[TBL] [Abstract][Full Text] [Related]
22. Biomedicine. Parkinson's--divergent causes, convergent mechanisms.
Greenamyre JT; Hastings TG
Science; 2004 May; 304(5674):1120-2. PubMed ID: 15155938
[No Abstract] [Full Text] [Related]
23. DJ-1 and UCH-L1 gene activity patterns in the brains of controls, Parkinson and schizophrenia patients and in rodents.
Galter D; Westerlund M; Belin AC; Olson L
Physiol Behav; 2007 Sep; 92(1-2):46-53. PubMed ID: 17599367
[TBL] [Abstract][Full Text] [Related]
24. DJ-1 interactions with α-synuclein attenuate aggregation and cellular toxicity in models of Parkinson's disease.
Zondler L; Miller-Fleming L; Repici M; Gonçalves S; Tenreiro S; Rosado-Ramos R; Betzer C; Straatman KR; Jensen PH; Giorgini F; Outeiro TF
Cell Death Dis; 2014 Jul; 5(7):e1350. PubMed ID: 25058424
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms of DJ-1 neuroprotection in a cellular model of Parkinson's disease.
Liu F; Nguyen JL; Hulleman JD; Li L; Rochet JC
J Neurochem; 2008 Jun; 105(6):2435-53. PubMed ID: 18331584
[TBL] [Abstract][Full Text] [Related]
26. DJ-1 associates with synaptic membranes.
Usami Y; Hatano T; Imai S; Kubo S; Sato S; Saiki S; Fujioka Y; Ohba Y; Sato F; Funayama M; Eguchi H; Shiba K; Ariga H; Shen J; Hattori N
Neurobiol Dis; 2011 Sep; 43(3):651-62. PubMed ID: 21645620
[TBL] [Abstract][Full Text] [Related]
27. DJ-1, a causative gene product of a familial form of Parkinson's disease, is secreted through microdomains.
Tsuboi Y; Munemoto H; Ishikawa S; Matsumoto K; Iguchi-Ariga SM; Ariga H
FEBS Lett; 2008 Jul; 582(17):2643-9. PubMed ID: 18586035
[TBL] [Abstract][Full Text] [Related]
28. Experimental encephalomyelitis induces changes in DJ-1: implications for oxidative stress in multiple sclerosis.
Lev N; Ickowicz D; Barhum Y; Blondheim N; Melamed E; Offen D
Antioxid Redox Signal; 2006; 8(11-12):1987-95. PubMed ID: 17034344
[TBL] [Abstract][Full Text] [Related]
29. Evidence for a common biological pathway linking three Parkinson's disease-causing genes: parkin, PINK1 and DJ-1.
van der Merwe C; Jalali Sefid Dashti Z; Christoffels A; Loos B; Bardien S
Eur J Neurosci; 2015 May; 41(9):1113-25. PubMed ID: 25761903
[TBL] [Abstract][Full Text] [Related]
30. Parkinson's disease-associated DJ-1 mutations impair mitochondrial dynamics and cause mitochondrial dysfunction.
Wang X; Petrie TG; Liu Y; Liu J; Fujioka H; Zhu X
J Neurochem; 2012 Jun; 121(5):830-9. PubMed ID: 22428580
[TBL] [Abstract][Full Text] [Related]
31. Reactive oxygen species-mediated DJ-1 monomerization modulates intracellular trafficking involving karyopherin β2.
Björkblom B; Maple-Grødem J; Puno MR; Odell M; Larsen JP; Møller SG
Mol Cell Biol; 2014 Aug; 34(16):3024-40. PubMed ID: 24912681
[TBL] [Abstract][Full Text] [Related]
32. DJ-1 deficiency triggers microglia sensitivity to dopamine toward a pro-inflammatory phenotype that is attenuated by rasagiline.
Trudler D; Weinreb O; Mandel SA; Youdim MB; Frenkel D
J Neurochem; 2014 May; 129(3):434-47. PubMed ID: 24355073
[TBL] [Abstract][Full Text] [Related]
33. Aggresome-forming TTRAP mediates pro-apoptotic properties of Parkinson's disease-associated DJ-1 missense mutations.
Zucchelli S; Vilotti S; Calligaris R; Lavina ZS; Biagioli M; Foti R; De Maso L; Pinto M; Gorza M; Speretta E; Casseler C; Tell G; Del Sal G; Gustincich S
Cell Death Differ; 2009 Mar; 16(3):428-38. PubMed ID: 19023331
[TBL] [Abstract][Full Text] [Related]
34. Protective effect of planarian DJ-1 against 6-hydroxydopamine-induced neurotoxicity.
Tsushima J; Nishimura K; Tashiro N; Takata K; Ashihara E; Yoshimoto K; Ariga H; Agata K; Kitamura Y
Neurosci Res; 2012 Dec; 74(3-4):277-83. PubMed ID: 23026478
[TBL] [Abstract][Full Text] [Related]
35. DJ-1 modulates alpha-synuclein aggregation state in a cellular model of oxidative stress: relevance for Parkinson's disease and involvement of HSP70.
Batelli S; Albani D; Rametta R; Polito L; Prato F; Pesaresi M; Negro A; Forloni G
PLoS One; 2008 Apr; 3(4):e1884. PubMed ID: 18382667
[TBL] [Abstract][Full Text] [Related]
36. A DJ-1 Based Peptide Attenuates Dopaminergic Degeneration in Mice Models of Parkinson's Disease via Enhancing Nrf2.
Lev N; Barhum Y; Ben-Zur T; Aharony I; Trifonov L; Regev N; Melamed E; Gruzman A; Offen D
PLoS One; 2015; 10(5):e0127549. PubMed ID: 26024237
[TBL] [Abstract][Full Text] [Related]
37. DJ-1-dependent protective activity of DJ-1-binding compound no. 23 against neuronal cell death in MPTP-treated mouse model of Parkinson's disease.
Takahashi-Niki K; Inafune A; Michitani N; Hatakeyama Y; Suzuki K; Sasaki M; Kitamura Y; Niki T; Iguchi-Ariga SM; Ariga H
J Pharmacol Sci; 2015 Mar; 127(3):305-10. PubMed ID: 25837927
[TBL] [Abstract][Full Text] [Related]
38. Involvement of ERK1/2 signaling pathway in DJ-1-induced neuroprotection against oxidative stress.
Gu L; Cui T; Fan C; Zhao H; Zhao C; Lu L; Yang H
Biochem Biophys Res Commun; 2009 Jun; 383(4):469-74. PubMed ID: 19371728
[TBL] [Abstract][Full Text] [Related]
39. Changes in the two-dimensional electrophoresis pattern of the Parkinson's disease related protein DJ-1 in human SH-SY5Y neuroblastoma cells after dopamine treatment.
Alberio T; Colapinto M; Natale M; Ravizza R; Gariboldi MB; Bucci EM; Lopiano L; Fasano M
IUBMB Life; 2010 Sep; 62(9):688-92. PubMed ID: 20836127
[TBL] [Abstract][Full Text] [Related]
40. Destabilization of DJ-1 by familial substitution and oxidative modifications: implications for Parkinson's disease.
Hulleman JD; Mirzaei H; Guigard E; Taylor KL; Ray SS; Kay CM; Regnier FE; Rochet JC
Biochemistry; 2007 May; 46(19):5776-89. PubMed ID: 17451229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
